In 2020, as the U.S. health care system faced the unprecedented challenge of combating the COVID-19 pandemic, telemedicine emerged as an invaluable care delivery tool; both providers and patients heavily relied on it for providing and receiving care. Through an analysis of National Electronic Health Record Survey (NEHRS) 2021 data and from in-house data collected from electronic health record (EHR) developers’ app galleries, we have an opportunity to inform the public about physicians’ experiences with telemedicine during the pandemic.

In 2020, the U.S. Department of Health and Human Services (HHS) released a strategy to reduce regulatory and administrative burden relating to the use of health IT, including electronic health record (EHR) systems. Key burden reduction goals addressed in the report include reducing the amount of time and effort required to record information in EHRs to meet regulatory requirements and improving the usability of EHRs.

In the midst of a growing drug overdose crisis exacerbated by the COVID-19 pandemic, clinicians’ use of prescription drug monitoring programs (PDMPs) and electronic prescribing of controlled substances (EPCS) technology is critical to improving opioid prescribing practices, informing treatment decisions, and supporting safe and effective patient care. Recent efforts, such as mandating use of EPCS technology and integrating PDMPs into electronic health record (EHR) systems, aim to improve prescribing practices by increasing the utility of information contained in PDMPs and decreasing prescription diversion and doctor shopping.